Hiroshi Ishiguchi

1.4k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Hiroshi Ishiguchi is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hiroshi Ishiguchi has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hiroshi Ishiguchi's work include DNA Repair Mechanisms (5 papers), ATP Synthase and ATPases Research (4 papers) and RNA modifications and cancer (3 papers). Hiroshi Ishiguchi is often cited by papers focused on DNA Repair Mechanisms (5 papers), ATP Synthase and ATPases Research (4 papers) and RNA modifications and cancer (3 papers). Hiroshi Ishiguchi collaborates with scholars based in Japan, United States and Netherlands. Hiroshi Ishiguchi's co-authors include Hiroto Izumi, Takayuki Torigoe, Yoichiro Yoshida, Kimitoshi Kohno, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Hidetaka Uramoto, Takeshi Yoshida and Minoru Nomoto and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Scientific Reports.

In The Last Decade

Hiroshi Ishiguchi

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

2003 543 citations Hiroto Izumi, Takayuki Torigoe et al. Cancer Treatment Reviews profile →

Peers

Countries citing papers authored by Hiroshi Ishiguchi

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Ishiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ishiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ishiguchi more than expected).

Fields of papers citing papers by Hiroshi Ishiguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ishiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ishiguchi. The network helps show where Hiroshi Ishiguchi may publish in the future.

Co-authorship network of co-authors of Hiroshi Ishiguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ishiguchi. A scholar is included among the top collaborators of Hiroshi Ishiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ishiguchi. Hiroshi Ishiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry 2024 ·European Heart Journal ·Bi Huang, (unknown), Hiroshi Ishiguchi, (unknown), Tze‐Fan Chao, Brian Olshansky, Menno V. Huisman, G Y H Lip	0
2	Predictive value of the neutrophil-to-lymphocyte ratio for treatment response in patients diagnosed with definite or probable autoimmune encephalitis/encephalopathy 2023 ·Frontiers in Neurology ·(unknown), (unknown), Katsuichi Miyamoto, Megumi Mori, Maiko Takahashi, (unknown), (unknown), (unknown), Yoshinori Kajimoto, Hiroshi Ishiguchi, Hidefumi Ito	1
3	Comparison of two families with and without ataxia harboring novel variants in PRKCG 2022 ·Journal of Human Genetics ·(unknown), Kodai Kume, (unknown), Tomoko Sekiya, Kazuto Nishinaka, Hiroshi Ishiguchi, (unknown), (unknown), (unknown), Takashi Kurashige, Yuishin Izumi, Hidefumi Ito, Norio Sakai, Hideshi Kawakami	1
4	Diagnostic utility of susceptibility-weighted imaging in amyotrophic lateral sclerosis 2022 ·Journal of the Neurological Sciences ·M Yasui, (unknown), (unknown), (unknown), (unknown), Hiroshi Ishiguchi, Hidefumi Ito	6
5	Association between oxidative stress and microRNA expression pattern of ALS patients in the high-incidence area of the Kii Peninsula 2020 ·Brain Research ·(unknown), Shunji Itoh, Yohji Fukazawa, Hiroshi Ishiguchi, (unknown), (unknown), Hidefumi Ito, Tameko Kihira	9
6	Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson’s disease 2020 ·Scientific Reports ·(unknown), Yoshiki Kaneoke, Tomohiro Donishi, Takuya Ishida, (unknown), (unknown), (unknown), M Yasui, Hiroshi Ishiguchi, (unknown), Kenya Murata, Masaki Terada, Hidefumi Ito	17
7	Chronic inflammatory demyelinating polyneuropathy associated with primary biliary cirrhosis 2013 ·Journal of Clinical Neuroscience ·Kenya Murata, Hiroshi Ishiguchi, (unknown), Hideto Miwa, Tomoyoshi Kondo	4
8	Neurosyphilis with Mesiotemporal Magnetic Resonance Imaging Abnormalities 2008 ·Internal Medicine ·(unknown), Hiroshi Ishiguchi, (unknown), Hideto Miwa, Tomoyoshi Kondo	23
9	3. Drug Induced Dyskinesia 2007 ·Nihon Naika Gakkai Zasshi ·Tomoyoshi Kondo, Hiroshi Ishiguchi	4
10	Cisplatin Resistance and Transcription Factors 2005 ·PubMed ·Takayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, Yoichiro Yoshida, Mizuho Tanabe, Takeshi Yoshida, Tomonori Igarashi, (unknown), Tetsuro Wakasugi, (unknown), Yasutomo Momii, Michihiko Kuwano, Kimitoshi Kohno	112
11	ZNF143 activates gene expression in response to DNA damage and binds to cisplatin‐modified DNA 2004 ·International Journal of Cancer ·Hiroshi Ishiguchi, Hiroto Izumi, Takayuki Torigoe, Yoichiro Yoshida, Hiroshi Kubota, Sadatoshi Tsuji, Kimitoshi Kohno	33
12	Binding of RNA to p53 regulates its oligomerization and DNA-binding activity 2004 ·Oncogene ·Yoichiro Yoshida, Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Takeshi Yoshida, Hideaki Itoh, Kimitoshi Kohno	35
13	P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. 2003 ·PubMed ·Yoichiro Yoshida, Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Hideaki Itoh, Dongchon Kang, Kimitoshi Kohno	157
14	Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy breakdown → 2003 ·Cancer Treatment Reviews ·Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Hidetaka Uramoto, Yoichiro Yoshida, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Takeshi Yoshida, Minoru Nomoto, Kimitoshi Kohno	543
15	Structural and functional characterization of two human V-ATPase subunit gene promoters 2003 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Hiroto Izumi, Tomoko Ise, Tadashi Murakami, Takayuki Torigoe, Hiroshi Ishiguchi, Hidetaka Uramoto, Yoichiro Yoshida, Takeshi Yoshida, Mizuho Tanabe, Kimitoshi Kohno	10
16	Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA 2002 ·Biochemical and Biophysical Research Communications ·Yoichiro Yoshida, Hiroto Izumi, Tomoko Ise, Hidetaka Uramoto, Takayuki Torigoe, Hiroshi Ishiguchi, Tadashi Murakami, Mizuho Tanabe, Yoshifumi Nakayama, Hideaki Itoh, Hiroshi Kasai, Kimitoshi Kohno	57
17	Enhanced Expression of the Human Vacuolar H+-ATPase c subunit Gene (ATP6L) in Response to Anticancer Agents 2002 ·Journal of Biological Chemistry ·Takayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, Hidetaka Uramoto, Tadashi Murakami, Tomoko Ise, Yoichiro Yoshida, Mizuho Tanabe, Minoru Nomoto, Hideaki Itoh, Kimitoshi Kohno	71
18	Vacuolar H+-ATPase: functional mechanisms and potential as a target for cancer chemotherapy 2002 ·Anti-Cancer Drugs ·Takayuki Torigoe, Hiroto Izumi, Tomoko Ise, Tadashi Murakami, Hidetaka Uramoto, Hiroshi Ishiguchi, Yoichiro Yoshida, Mizuho Tanabe, Minoru Nomoto, Kimitoshi Kohno	46
19	Lattice Corneal Dystrophy Type II Associated with Familial Amyloid Polyneuropathy Type IV 1996 ·Ophthalmology ·S Akiya, (unknown), (unknown), (unknown), Hiroshi Takahashi, (unknown), Akio Onishi, Hiroshi Ishiguchi, (unknown), Masamitsu Nakazato	17
20	[Familial amyloidosis, Finnish type with marked anhidrosis]. 1996 ·PubMed ·Hiroshi Ishiguchi, (unknown), (unknown), Yasuhisa Murai, Masamitsu Nakazato, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact